Production (Stage)
BIOQUAL, Inc.
BIOQ
$43.19
-$0.25-0.58%
OTC PK
| 02/28/2025 | 11/30/2024 | 08/31/2024 | 02/29/2024 | 11/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 14.03M | 11.40M | 11.77M | 15.34M | 15.87M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 14.03M | 11.40M | 11.77M | 15.34M | 15.87M |
| Cost of Revenue | 11.30M | 11.51M | 11.33M | 13.00M | 13.33M |
| Gross Profit | 2.73M | -113.60K | 437.30K | 2.35M | 2.54M |
| SG&A Expenses | 1.56M | 1.71M | 1.57M | 2.11M | 1.97M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 12.86M | 13.22M | 12.90M | 15.10M | 15.31M |
| Operating Income | 1.17M | -1.82M | -1.13M | 242.00K | 562.40K |
| Income Before Tax | 1.29M | -1.67M | -931.80K | 379.20K | 668.60K |
| Income Tax Expenses | 355.30K | -460.20K | -256.50K | 104.20K | 183.90K |
| Earnings from Continuing Operations | 936.00K | -1.21M | -675.30K | 275.00K | 484.70K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 936.00K | -1.21M | -675.30K | 275.00K | 484.70K |
| EBIT | 1.17M | -1.82M | -1.13M | 242.00K | 562.40K |
| EBITDA | 1.77M | -1.23M | -512.10K | 881.60K | 1.20M |
| EPS Basic | 1.05 | -1.36 | -0.76 | 0.31 | 0.54 |
| Normalized Basic EPS | 0.90 | -1.17 | -0.65 | 0.27 | 0.47 |
| EPS Diluted | 1.05 | -1.36 | -0.76 | 0.31 | 0.54 |
| Normalized Diluted EPS | 0.90 | -1.17 | -0.65 | 0.27 | 0.47 |
| Average Basic Shares Outstanding | 894.40K | 894.40K | 894.40K | 894.40K | 894.40K |
| Average Diluted Shares Outstanding | 894.40K | 894.40K | 894.40K | 894.40K | 894.40K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | 0.00% | -36.89% | -- | 0.00% | 92.27% |